Trajan : Capital Raising Presentation

This presentation is dated 17 June 2022 and has been prepared by Trajan Group Holdings Limited (ACN 152 617 706) (Company or Trajan) in connection with (a) Trajan's proposed acquisition of Chromatography Research Supplies, Inc. (CRS)

(Acquisition); (b) an institutional placement of new fully paid ordinary shares (New Shares) in the Company (Placement); and (c) an offer of New Shares to eligible shareholders under a share purchase plan (SPP) (the Placement and SPP together

being the Offer). The Placement is jointly managed and fully underwritten by Canaccord Genuity (Australia) Limited and Ord Minnett Limited (the Joint Lead Managers) on the terms and conditions of an Underwiring Agreement dated 17 June 2022

only

between the Joint Lead Managers and the Company. The SPP is not underwritten. By receiving this presentation, you are agreeing to the following restrictions and limitations.

Summary information

This presentation contains summary information about the Company's activities current as at the date of this presentation. The information in this presentation is of a general background nature and does not purport to be complete, include all information

that prospective investors would require to evaluate an investment in the Company, nor does it contain all of the information which would be required to be disclosed in a prospectus, product disclosure statement or other offer document under Australian

law or under any other law. This presentation has not been filed, registered or approved by regulatory authorities in any jurisdiction. This presentation should be read in conjunction with the Company's periodic and continuous disclosure announcements

filed with the Australian Securities Exchange, available at www.asx.com.au(ASX Code: TRJ) and at https://investor.trajanscimed.com/. Certain information in this presentation has been sourced from the vendor, its representatives or associates, in

relation to the Acquisition. As described further in the risk factors outlined in Appendix 1 of this presentation, while steps have been taken to review that information, no representation or warranty, expressed or implied, is made as to its fairness,

accuracy, correctness, completeness or adequacy.

Not an offer

use

This presentation is for information purposes only and is not a prospectus, product disclosure statement or other disclosure or offering document under Australian law. This presentation is not, and does not constitute an offer to sell or the solicitation,

invitation or recommendation to purchase any security (including New Shares) or any other financial product, nor does it constitute financial product advice. Neither this document nor any of the information contained herein shall form the basis of any

contract or commitment.

The Placement will be conducted under section 708A of the Corporations Act 2001 (Cth) (Corporations Act) and will be made available to certain persons who are institutional investors. The SPP will only be made available to eligible shareholders in

A

stralia and New Zealand and will be conducted in accordance with ASIC Corporations (Share and Interest Purchase Plans) Instrument 2019/547. Determination of eligibility of investors for the purposes of the Offer is determined by reference to a

n

mber of matters, including legal requirements and the discretion of the Company and the Joint Lead Managers. To the maximum extent permitted by law, the Company and the Joint Lead Managers each disclaim any liability in respect of the exercise

of that discretion or otherwise.

ersonal

This presentation does not constitute an offer to sell, or a solicitation of an offer to buy, any securities in the United States. The securities referred to in this presentation have not been, and will not be, registered under the Securities Act of 1933 (US

Securities Act) or the securities laws of any state or other jurisdiction of the United States and may not be offered or sold in the United States unless the securities have been registered under the US Securities Act or are offered and sold in a

tr

nsaction exempt from, or not subject to, the registration requirements of the US Securities Act and any other applicable securities laws. The distribution of this document in jurisdictions outside Australia may be restricted by law and you should observe

ny such restrictions. If you come into possession of this presentation, you should observe such restrictions. Any non-compliance with these restrictions may contravene applicable securities laws. Refer to the "Foreign Selling Restrictions" section in this

presentation for more information. By accessing this presentation, you represent and warrant that you are entitled to receive such presentation in accordance with these restrictions and agree to be bound by the limitations contemplated by them.

Not financial product advice or an offer

The information in this presentation does not constitute financial product or investment advice (nor tax, accounting or legal advice), nor is it a recommendation to subscribe for or acquire New Shares and does not and will not form any part of any contract

f

r the subscription or acquisition of New Shares. This presentation does not take into account the investment objectives, financial situation, taxation situation or needs of any particular investor. Prospective investors should consider the appropriateness

of the information having regard to their own investment objectives, individual financial circumstances and seek legal, accounting and taxation advice appropriate to their jurisdiction, before making any investment decision. The Company is not licensed

only

Investors should note that financial data in this presentation includes "non-IFRS financial information" under Regulatory Guide 230 (Disclosing non-IFRS financial information) published by the Australian Securities and Investments Commission and also

"non-GAAP financial measures" within the meaning of Regulation G of the US Securities Exchange Act of 1934 and have not been audited or reviewed. The non-IFRS/non-GAAP measures in this presentation include Normalised EBITDA. The Company

believes this non-IFRS/non-GAAP financial information provides useful information to users in measuring the financial performance and conditions of the Company. The non-IFRS financial information and these non-GAAP financial measures do not

have a standardised meaning prescribed by AIFRS and therefore may not be comparable to similarly titled measures presented by other entities, nor should they be construed as an alternative to other financial measures determined in accordance with

AIFRS. Investors are cautioned not to place undue reliance on any non-IFRS financial measures included in this presentation.

Effect of rounding

A number of figures, amounts, percentages, estimates, calculations of value and fractions in this presentation are subject to the effect of rounding. Accordingly, the actual calculation of these figures may differ from the figures set out in this presentation.

Disclaimer

use

No r presentation or warranty, express or implied, is made as to the accuracy, reliability, completeness or fairness of the information, opinions and conclusions contained in this presentation. To the maximum extent permitted by law, neither the

Company, its related bodies corporate, shareholders or affiliates, nor any of their respective officers, directors, employees, affiliates, agents or advisers, nor any Limited Party, guarantees or makes any representations or warranties, express or implied,

as to or takes responsibility for, the accuracy, reliability, completeness, currency or fairness of the information, opinions and conclusions contained in this presentation. The Company does not represent or warrant that this presentation is complete or that

it contains all material information about the Company or which a prospective investor or purchaser may require in evaluating a possible investment in the Company, or an acquisition or other dealing in the Company shares. To the maximum extent

permitted by law, the Company and each Limited Party expressly disclaim any and all liability, including, without limitation, any liability arising out of fault or negligence, for any direct, indirect, consequential or contingent loss or damage arising from the

se of information contained in this presentation, including representations or warranties or in relation to the accuracy or completeness of the information, statements, opinions or matters, express or implied, contained in, arising out of or derived from, or

for omissions from, this presentation including, without limitation, any financial information, any estimates or projections and any other financial information derived therefrom.

Statements made in this presentation are made only at the date of the presentation. The Company is under no obligation to update this presentation. The information in this presentation remains subject to change by the Company without notice. The

Company reserves the right to withdraw or vary the timetable for the Offer without notice.

ersonal

4